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Abstract: The surface functionalization of magnetic nanoparticles improves their physicochemical
properties and applicability in biomedicine. Natural polymers, including proteins, are prospective
coatings capable of increasing the stability, biocompatibility, and transverse relaxivity (r2) of magnetic
nanoparticles. In this work, we functionalized the nanoclusters of carbon-coated iron nanoparticles
with four proteins: bovine serum albumin, casein, and gelatins A and B, and we conducted a
comprehensive comparative study of their properties essential to applications in biosensing. First,
we examined the influence of environmental parameters on the size of prepared nanoclusters and
synthesized protein-coated nanoclusters with a tunable size. Second, we showed that protein coating
does not significantly influence the r2 relaxivity of clustered nanoparticles; however, the uniform
distribution of individual nanoparticles inside the protein coating facilitates increased relaxivity. Third,
we demonstrated the applicability of the obtained nanoclusters in biosensing by the development of a
nuclear-magnetic-resonance-based immunoassay for the quantification of antibodies against tetanus
toxoid. Fourth, the protein coronas of nanoclusters were studied using SDS-PAGE and Bradford
protein assay. Finally, we compared the colloidal stability at various pH values and ionic strengths
and in relevant complex media (i.e., blood serum, plasma, milk, juice, beer, and red wine), as well as
the heat stability, resistance to proteolytic digestion, and shelf-life of protein-coated nanoclusters.
Keywords: nanoparticles; protein; assay; colloidal stability; antibody; protein G; streptavidin
1. Introduction
Magnetic nanoparticles find application in numerous fields of biomedicine, including drug delivery,
tissue engineering, bioimaging, biosensing, and many others [1,2]. The magnetic nanoparticle-assisted
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isolation of cells, proteins, DNA, and other analytes from such complex matrices as whole blood,
blood serum or plasma, urine, tissue extracts, food, and liquor are a powerful tool in biosensing,
facilitating increases in analytical sensitivity and specificity [3]. Recently, magnetic nanoparticles have
been extensively used in optical, electrochemical, and piezoelectric sensors, as well as in colorimetric
point-of-care tests serving as tags, carriers of labels (e.g., enzymes), or both [4,5].
Nuclear magnetic resonance (NMR)-based biosensing is an area where magnetic nanoparticles are
filling an extremely important role. The ability of magnetic nanoparticles to perturb the precession of nuclear
spins in surrounding water protons stipulates their application in vivo as a magnetic resonance imaging
(MRI) contrast [6] and in vitro as a nanoprobe for NMR-relaxometry [7]. There are two main approaches
to in vitro NMR-assays. The first is a magnetic relaxation switch (MRSw), which relies on the aggregation
of magnetic nanoparticles caused by the addition of an analyte. The aggregation/disaggregation of
nanoparticles leads to a change in transverse relaxation time of protons (T2). The second approach is based
on the binding of magnetic nanoparticles to the target and the removal of unbound particles. In this case,
the relaxation time depends on the number of nanoparticles in the sample; this number is proportional to
the analyte concentration. A detailed description of the principles underlying NMR sensors can be found
in reviews [8–10]. NMR sensing platforms exploiting magnetic nanoparticles are used in food safety
assessment; the diagnostics of sepsis, hemostatic disorders, and infectious diseases; and the detection of
extracellular vesicles, tumor markers, enzymes, and ions [10–12]. Despite great progress in the field of
magnetic sensing, improvements in the stability, relaxivity, and biocompatibility of magnetic nanolabels
are of great importance for both in vivo and in vitro diagnostics [7,13,14].
Magnetic nanoparticles, a key element of NMR sensors, suffer from an instability in water solutions,
the nonspecific sorption of molecules from the environment, and a lack of surface functional groups.
Numerous surface coatings have been developed to address these challenges: polymers (e.g., dendrimers,
polyvinylpyrrolidone, polyethylene glycol (PEG) and polyethyleneimine), zwitterions, small molecules
(e.g., citrate), and inorganic materials (e.g., silica and gold) [6,15]. Proteins and polypeptides, as well
as carbohydrates and lipids, are other prospective shielding agents to endow magnetic nanoparticles
with stability in physiological media, biocompatibility, stealth properties, and multiple surface functional
groups [16–22].
The goal of this study is to provide a direct comparison of the colloidal stability, functional activity,
and physical-chemical properties of nanoclusters consisting of magnetic carbon-encapsulated iron
nanoparticles coated with four proteins widely used in biomedicine: bovine serum albumin (BSA),
casein, and gelatins A and B. We studied these nanoconjugates in the context of their application for
in vitro assays, and more specifically, for T2 relaxometry. We chose the mentioned proteins for the
following reasons:
(1) Serum albumin and casein coatings can increase the r2 relaxivity of magnetic nanoparticles
due to their high hydrophilicity and ability to retain water molecules [13,23]. Gelatin has a strong
affinity toward water molecules [24]; therefore, it is of great importance to reveal whether it can also
increase relaxivity of magnetic nanoparticles.
(2) All proteins under study are extensively used for the preparation of nanoplatforms in drug
delivery and theranostics because of their biocompatibility and excellent stability in physiological
solutions [20,25,26]. The potential risks of human exposure to nanoparticles are still not well
understood [27]; therefore, it is essential to ensure the biocompatibility of nanomaterials, even when
they are designed for in vitro applications.
(3) BSA, gelatin, and casein are widely utilized as carriers for fluorophores, T1-contrast agents,
enzymes, and therapeutics [20,25,26], therefore, the loading of a protein coating with agents providing
multimodal biosensing is available.
(4) Albumin coatings decrease the nonspecific adsorption of serum proteins on the nanoparticles’
surface [17], facilitating a reduction in false-negative results for assays.
(5) Bovine serum albumin, casein, and gelatin are relatively inexpensive and widely
available biopolymers.
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To our knowledge, there remains a lack of comprehensive comparative studies of magnetic
nanoparticles with different protein coatings. It is important that we examine the properties of
protein-coated nanoclusters in parallel under the same conditions; we believe that only such an
approach can provide an accurate comparison.
2. Materials and Methods
2.1. Materials
Fe@C nanoparticles were synthesized as described elsewhere [28]. Sepharose CL-6B was from GE
Healthcare (USA), nitrocellulose membrane SCWP, 8 µm pore size was from Merck (USA). Dialysis
tubing with 10 kDa MWCO was from Thermo (USA). Bovine serum albumin (heat shock isolation),
agarose was from Amresco (USA), casein (lot# C5890), gelatin type A gel strength 300 (lot# G2500),
gelatin type B gel strength 75 (lot# G6650), biotinamidohexanoic acid N-hydroxysuccinimide ester,
PEG 35 kDa, sodium dodecyl sulfate (SDS), β-mercaptoethanol, 4-aminobenzylamine, NaNO2 were
from Sigma-Aldrich (USA). Streptavidin was from ProspecBio (Israel), recombinant protein G from
Streptococcus sp. was kindly provided by Dr. Tatyana Gupalova, Institute of Experimental Medicine
(St.-Petersburg, Russia). Tetanus toxoid was from Mikrogen (Russia), WHO standard of anti-tetanus
IgG (TE-3) was from NIBSC (UK), sodium azide, ammonium persulphate, and glutaraldehyde (50%)
were from AppliChem (Germany). Sodium hydroxide, glycerol, sodium chloride, sodium hydrogen
phosphate, sodium dihydrogen phosphate, and Tween-20 were from Panreac (Spain). Bradford reagent,
acrylamide, TEMED, Coomassie Brilliant Blue G-250, Bromphenol Blue were from Bio-Rad (USA),
trypsin was from Samson-Med (Russia).
The following solutions were used: phosphate buffer solution (PBS, 0.15 M NaCl, 0.015 M
Na2HPO4, 0.015 M NaH2PO4, and 0.1% NaN3, pH 7.25) and PBS-Tw (PBS + 0.1% Tween-20). A 25%
(v/v) glutaraldehyde solution with pH 7.25 was prepared by mixing of 50% glutaraldehyde with PBS;
pH and ionic strength were adjusted with 1 M NaOH and 5 M NaCl respectively. The solution of
casein in water was prepared as follows: first, 2.5 mg of casein powder was diluted in 47.5 mL 1 M
NaOH and dialyzed twice against 5 L of 0.1M NaCl and once against 5 L of deionized water; then
casein was concentrated to 25–30 mL using PEG 35000 and centrifuged at 20,000× g for 100 min to
remove the most of micelles (Figure S1). The final concentration of casein (8.8%) was determined using
an extinction coefficient of 0.81 L·g−1·cm−1 [29]. All solutions were prepared using deionized water.
Blood serum samples were from volunteers aged from 21 to 58 years. All the procedures performed
in the studies involving human participants were in accordance with the 1964 Declaration of Helsinki
and its later amendments or comparable ethical standards. This research was approved by the Review
Board of the Institute of Ecology and Genetics of Microorganisms UB RAS (IRB00010009). Written
informed consent was obtained from the volunteers.
The following equipment was used: UV-VIS spectrophotometer Shimadzu UVmini 1240, an
Asylum Research atomic-force microscope (United States), an MSE Soniprep 150 sonicator, a Malvern
ZetaSizer Nano ZS particle analyzer, TGA/DSC1 (Mettler-Toledo) was employed to perform the
thermogravimetric analysis (TGA), chromatography columns XK 16/40 and C 10/10, peristaltic pump
P-1 were from GE Healthcare (USA), Mini Protean tetra cell and Mini-Sub GT cell for vertical and
horizontal electrophoresis were from Bio-Rad.
A custom-made NMR relaxometer was used for the NMR-assay of antibodies and nanoparticle
stability studies. The magnet assembly of the device was based on permanent SmCo magnets with
a field of ~2 kOe (0.2 Tesla), with a heterogeneity of no more than 3 × 10−5 in the sample volume
(1 cm3), that provides a measuring frequency of approximately 7.75 MHz. The reference frequency of
the device was adjusted with an accuracy of 10 Hz to the Larmor resonance frequency of water protons
in the sample to compensate for the temperature drift of the field before the measurement.
The device was based on the Analog Devices BF-937 DSP processor. Communication with a
computer was carried out via USB; custom-made software was used to interact with a PC, through
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which the device was controlled. The same software was used for the mathematical processing of the
results, including the calculation of the relaxation times.
The measuring unit was inserted into the magnet assembly of the NMR relaxometer and consisted
of radio-frequency coils and capacitors in a 3D-printed plastic (PLA) case. Two different measuring
units were constructed: one for liquid samples, from 10 to 100 µL, placed in the wells of a standard
96-well-striped ELISA plate, and the other one with a flattened coil (10 × 10 × 1 mm) for the NMR
measurement of liquids in flat porous membranes. For the well-based measuring system, the SNR
(signal-to-noise ratio) was 43 for a liquid volume of 10 µL and 378 for a liquid volume of 100 µL. For
the planar system, the SNR was 15 for a liquid volume of 10 µL in the membrane; this value was more
than enough to make reliable measurements of the relaxation times.
2.2. Preparation of Aminated Fe@C (Fe@C-NH2)
First, 100 mg of Fe@C powder was added to 10 mL of 1 M HCl and left for 60 min at room
temperature (RT), then washed five times with 10 mL of deionized water using magnetic separation
and redispersed in 10 mL of 1 M HCl. Next, 120 µL of 4-aminobenzylamine (4-ABA) was added;
afterwards, a glass tube with nanoparticles was placed at −20 ◦C for 30 min, then 70 mg of NaNO2
was added, and the resulting mixture was sonicated (6 mm probe, 100% amplification). When heating
produced by the sonicator led to boiling and foaming, the sonication was interrupted to allow cooling.
The total time of sonication was 60 min. Afterwards, the suspension was placed in 10 kDa MWCO
dialysis tubing and dialyzed three times against 2 L of deionized water. The resulting suspension
was transferred into the plastic tube and stored at +4 ◦C; then, 100 µL of 1 M HCl was added to
prevent sedimentation of aminated nanoparticles. The concentration of Fe@C-NH2 was determined by
thermogravimetric analysis (TGA) and can be found in the table (Table S1).
2.3. Influence of pH, Ionic Strength and Protein-to-Nanoparticle Ratio on the Size of Protein-Coated Nanoclusters
Casein, BSA, and gelatins A and B were diluted in buffers with pH that ranged from 4 to 9
(pH 4 and 5—acetic buffer, pH 6, 7, and 8—phosphate buffer, and pH 9—borate buffer). The initial
ionic strength of the buffers was 0.01 M, and it was adjusted to 0.15 and 0.5 M with 5 M NaCl where
necessary. Fifty microliters of 10 mg/mL Fe@C-NH2 was added dropwise under vortex stirring, then
water and 1 M NaOH/1 M HCl were added to make a final volume of 500 µL and a pH of 7.2–7.6.
The resulting protein-to-nanoparticle mass ratios were 10:1, 5:1, 2.5:1, and 1.25:1. The suspensions were
sonicated for 10 s (30% amplification, 3 mm probe), added while vortexing to an equal volume of 25%
glutaraldehyde solution (see Section 2.1) and incubated for 30 min on a rotating mixer. For BSA and
casein, all steps were carried out at room temperature, while the gelatin solutions and gelatin-coated
nanoclusters were kept at +37–+40 ◦C to prevent gelation.
2.4. Synthesis of Protein-Coated Fe@C-NH2 Nanoclusters Conjugated with Streptavidin and Streptococcal
Protein G
The general protocol for nanocluster conjugation with affine compounds is described in this
section. The details of the synthesis procedure depended on the type of protein coating (BSA, casein,
and gelatins type A and B), target nanocluster size, recognition molecule (streptavidin or protein G)
and purpose (e.g., we did not add BSA, glycerol, or glycine to conjugates that were used in the UV-VIS,
proteolysis, and protein corona studies) and can be found in Supporting Information.
The suspension of Fe@C-NH2 (10 mg/mL) was added dropwise under vortex stirring into a protein
solution. Where necessary, the pH was adjusted to 7.25 with 1 M NaOH, and the volume was adjusted
with PBS. The final protein-to-nanoparticle ratio (mg:mg) was 5:1. The resulting suspension was added
dropwise under vortex stirring to an equal volume of a 25% glutaraldehyde solution (see Section 2.1)
and incubated on a rotating mixer (hereinafter, the rotation angle was set to 99◦, and the rotation rate
was 5 rpm) for 30 min. Then, the nanoclusters treated with glutaraldehyde were passed through
a chromatography column to remove the excess of coating protein and glutaraldehyde. Fractions
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containing Fe@C-NH2/Protein nanoclusters were collected and concentrated in dialysis tubing (10 kDa
MWCO, 2 mL/m) covered with a layer of 35 kDa PEG. In 2–3 h, the concentrated suspension was
removed from the dialysis tubing and centrifuged at 1600× g for 5 min. The supernatant containing
Fe@C-NH2/Protein nanoclusters activated with glutaraldehyde was added to a solution of the desired
recognition molecule (streptavidin or protein G) in PBS under vortex stirring. The final recognition
molecule-to-Fe@C-NH2/Protein ratios (µg:mg) were 10:1. 20:1, 40:1, 80:1, and 160:1. Conjugation was
carried out overnight in a rotating mixer at +4 ◦C; glycine was added up to 6 mM to quench unreacted
aldehyde groups, and the mixture was incubated at RT for one more hour. The excess of reactants
was removed by gel-chromatography. The fractions with the highest concentration of nanoclusters
were combined. Glycerol, BSA, and glycine were added to the final concentrations of 20%, 1%, and
6 mM, respectively. The conjugates were stored at +4 ◦C. The concentration of nanoclusters was
determined by the absorbance at 450 nm, taking into account that the absorbance of a suspension of
protein-coated nanoclusters with a known concentration (before the addition of glutaraldehyde) was
preliminarily measured.
2.5. Assessment of Functional Activity of Protein-Coated Nanoclusters and Determination of Anti-Tetanus
Toxoid in Serum Samples by NMR-Based Assay
The solid phase NMR-based immunoassay on nitrocellulose strips was used to assess the
functional activity of different sizes of Fe@C-NH2/Protein/Str. Test-strips (5 mm × 60 mm) were cut
from nitrocellulose with an 8 µm pore size. The test-strips were soaked in PBS for 5 min at +37 ◦C.
Two microliters of biotinylated BSA (Bi-BSA) 10-fold diluted in PBS (from 100 µg/mL to 0.1 µg/mL)
was spotted onto wet strips [30], which were further dried at +37 ◦C for 30 min and at RT for 15 min.
Two microliters of 100 µg/mL BSA was spotted in the control zone. All subsequent steps were
performed at +37 ◦C on an orbital shaker except for the measurement. The test-strips were blocked in
3.5 mL of 1% BSA in PBS-Tw, washed three times for 5 min in 5 mL of PBS-Tw, incubated in 3.5 mL of a
0.05 mg/mL solution of Fe@C-NH2/Protein/Str in PBS-Tw with 1% BSA for 60 min, and then washed
12 times in 5 mL of PBS-Tw. Parts of the test strip with spotted Bi-BSA were placed inside the coil of
the relaxometer.
For the detection of the anti-tetanus toxoid IgG, a nitrocellulose membrane with a pore size
of 8 µm was cut into 6 mm × 80 mm pieces and soaked in PBS for 5 min at +37 ◦C. Then, the wet
membrane was incubated in 1.5 mL of a 20 µg/mL solution of tetanus toxoid in PBS for 30 min, dried
successively at +37 ◦C for 30 min and at room temperature for 15 min, blocked in 1.5 mL of 1% BSA +
2% casein in PBS-Tw and triple washed with 1.5 mL of PBS-Tw for 5 min. Then, membranes coated
with the tetanus toxoid were cut into 16 pieces (6 mm × 5 mm) (further referred to as “test strips”)
which were used in subsequent procedures. The test strips were incubated in 400 µL of serum samples
diluted 200-fold in PBS-Tw with 1% BSA and 2% casein for 60 min, washed three times with 600 µL
of PBS-Tw and incubated in 400 µL of 0.05 mg/mL Fe@C-NH2/Protein/G (nanoclusters conjugated
with protein G) in PBS-Tw with 2% casein for 60 min and washed 12 times. Solutions of the WHO
anti-tetanus toxoid standard TE-3 in blocking buffer were used to make a calibration curve. All samples
and calibrators were tested in triplicate. The measurement of T2 was performed by placing test strips
inside the coil of the relaxometer. All assay steps were carried out at +37 ◦C on an orbital shaker except
for the measurement.
2.6. Agarose Gel Electrophoresis
Agarose gel electrophoresis was used to study the size of nanoclusters and confirm the presence of
a protein coating on their surface [31]. Samples (5 µL per well) were run in 0.5% agarose gel in 0.5 × TBE
(Tris-borate) buffer, pH 8.3 at 75V. After that, gels were stained with staining solution containing 0.25 g
Coomassie Brilliant Blue R250 in 100 mL of fixing solution: methanol:acetic acid:water = 4:1:4 and
destained with fixing solution.
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2.7. Protein Corona Study
In these experiments, Fe@C-NH2/Protein/Str conjugates were used without stabilizers (1% BSA
and 20% glycerol), because they can interfere with the test results. The detailed preparation of the
conjugates for these experiments is described in the Supporting Information. Different volumes of
Fe@C-NH2/BSA/Str, Fe@C-NH2/Casein/Str, Fe@C-NH2/Gelatin B/Str, and Fe@C-NH2/Gelatin A/Str
suspensions containing 100µg of nanoclusters were centrifuged for 90 min at 10,000× g. The supernatant
was removed, and 100 µL of whole human serum or plasma (pooled serum/plasma from several
donors) was added to achieve a final concentration of nanoclusters of 1 mg/mL. To study protein
adsorption on the noncoated aminated nanoparticles, 10 µL of 10 mg/mL Fe@C-NH2 was mixed with
serum/plasma without prior centrifugation. The nanoparticles or nanoclusters were sonicated for 1 s
(30% amplification, 3 mm probe), vortexed and kept on a rotator in a thermostat at +37 ◦C for 1 h.
The fact that ultrasound can damage biopolymers is known [32], thus, we preliminarily confirmed that
centrifugation and sonication did not affect the size and zeta potential of the nanoclusters. Unbound
proteins were removed by washing with 1 mL PBS three times with centrifugation at 20,000× g for
15 min. The sedimented nanoclusters were mixed with 20 µL of sample buffer (0.5 M Tris-HCl pH
6.8, 5% β-mercaptoethanol, 10% SDS, 50% Glycerol, and 0.1% bromophenol blue), heated for 5 min
at +95 ◦C and sonicated as described above. Ten microliters were loaded into the wells containing a
10% polyacrylamide gel, and then, the samples were run at 100 V per gel in Tris-HCl buffer until the
proteins neared the end of the gel. The quantification of adsorbed proteins was carried out as follows.
The samples were prepared in the same way except the proteins were eluted using 50 µL PBS containing
0.025% SDS and 4 M urea with heating (+95 ◦C, 5 min); the urea and SDS in mentioned concentrations
do not interfere with the Bradford assay according to the manufacturer. The eluted serum proteins were
separated by centrifugation (10,000× g, 15 min), and then, the protein concentration was determined
by the Bradford assay (5 µL of undiluted sample + 250 µL Bradford reagent) using BSA to obtain a
calibration curve. Samples without the addition of serum were used as a control. The concentrations of
eluted proteins in the control samples were subtracted from those of the test samples. Three replicates
were made for both test and control samples.
2.8. Thermal Stability of Nanoclusters
Forty microliters of Fe@C-NH2/Protein/G, supplemented with 1% BSA, 20% glycerol and 6 mM
glycine, was incubated at temperatures ranged from +40 to +100 ◦C in a dry block thermostat for
60 min. The samples were diluted to 1:500 in PBS for the dynamic light scattering (DLS) measurements.
Three replicates were made for each sample. The control samples were kept at room temperature
throughout the experiment.
2.9. UV-VIS Spectrophotometry
Suspensions of Fe@C-NH2/Protein/Str in PBS without stabilizers (BSA, glycine, and glycerol) were
diluted in PBS, and their spectra were registered using PBS as a blank. Fe@C-NH2 was diluted in 0.1 M
acetic buffer at pH 4 and measured against this buffer.
2.10. Thermogravimetric Analysis
A total of 200 µL Fe@C-NH2 and Fe@C-NH2/BSA/Str samples were dried at 100 ◦C and placed in
the TGA furnace. The measurement was carried out under air at a heating rate of 10 K·min−1 from 25
to 1000 ◦C.
2.11. Dynamic Light Scattering (DLS)
The zeta potential and mean hydrodynamic diameter of the nanoclusters were measured by
dynamic light scattering.
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For size measurements, the samples were diluted to 1:500 (3 µL of nanoclusters suspension +
1500 µL of buffer) in buffers, which were preliminarily filtered through a polyethersulfone syringe filter
with an average pore size of 0.2 µm to remove dust, and pipetted into plastic cuvettes (12 × 12 mm).
Measurements were performed at a scattering angle of 173◦ in auto mode. A general purpose model
was used to fit the data. The intensity-weighted size (main peak) is reported throughout the article
unless otherwise stated.
For the zeta potential measurements, samples were diluted to 1:100 in deionized water (7 µL of
nanoclusters suspension + 700 µL of water) in the same cuvettes. The measurements were performed
in auto mode using a Dip Cell electrode (Malvern, UK). All measurements were done in triplicate.
2.12. Atomic Force Microscopy (AFM)
The samples of Fe@C-NH2/Protein/Str without stabilizers (BSA, glycerol, and glycine) were diluted
with water to 10 µg/mL, and then, a drop of the sample suspension was placed onto a microscopic
glass slide and dried at room temperature for 30–40 min.
2.13. Colloidal Stability of Nanoclusters
The assessment of colloidal stability utilized DLS, and the following buffers were used: 0.1 M
acetate buffer (pH 4 and 5), 0.05 M sodium phosphate buffer (pH 6, 7, and 8), 0.1 M sodium borate
buffer (pH 9 and 10). The ionic strength was adjusted to 0.15, 0.5, and 2 M using NaCl. All buffers
were filtered through 0.2 µm polyethersulfone syringe filters and contained 0.1% sodium azide as a
preservative. The samples of Fe@C-NH2/Protein/G were diluted to 20 µg/mL for the final volume of
750 µL in disposable plastic cuvettes. Three independent samples were prepared for each condition
tested. After agitation for 60 min at room temperature, the size of the nanoclusters was measured by
DLS. Then, the cuvettes with samples were left in a humidified chamber at room temperature, and
repeated measurements were made in 24 h.
The colloidal stability was also assessed by NMR relaxometry. The samples of Fe@C-NH2/Protein/G
were diluted to 10 µg/mL in 500 µL of the buffer, and then, 100 µL samples were added to the wells of
a 96-well polystyrene plate and placed inside the relaxometer’s coil. The buffers and time points were
the same.
2.14. Storage Stability of Protein-Coated Nanoclusters
The samples of Fe@C-NH2/Protein/G in PBS with 1% BSA, 20% glycerol and 6 mM glycine were
stored at +4 and +37 ◦C (one sample per conjugate). Their hydrodynamic diameter was monitored
throughout one month. The conjugates were diluted to 1:350 in 750 µL of filtered PBS. The size was
measured in triplicate: three independent dilutions of each sample.
Samples of Fe@C-NH2/Protein/Str conjugates from the size-tuning study were stored at +4 ◦C for
3–4 months, and their size was measured in the same way.
2.15. Stability of Nanoclusters in Complex Media
Red wine, orange juice, beer, and milk were purchased from the local supermarket. Pooled blood
serum/plasma from three healthy individuals was thawed and centrifuged at 10,000× g for 15 min
to remove aggregates. Fe@C-NH2/Protein/Str and Fe@C-NH2/Protein/G were diluted to 10 µg/mL in
500 µL of each medium, and then, 100 µL samples were added into the wells of a 96-well polystyrene
plate and placed inside the relaxometer’s coil. Measurements were taken immediately upon the
addition of nanoclusters and then after 1 and 5 h. The samples were kept at room temperature
throughout the study.
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2.16. Stability of Nanoclusters to Proteolytic Digestion
The samples of Fe@C-NH2/Protein/Str without stabilizers (BSA, glycerol, and glycine) were diluted
to 10 µg/mL with PBS (control samples) or with PBS containing 100 µg/mL of trypsin (test samples).
The samples were kept at +37 ◦C in Eppendorf tubes (three tubes for each type of protein coating) in a
dry block thermostat for 24 h. The size of the nanoclusters in test samples was measured from 5 to
30 min after the initial mixture and then after 1, 2, and 24 h; the control samples were measured after 2
and 24 h.
2.17. Determination of Nanoparticles’ Relaxivity
The relaxation measurements were carried out using the homemade portable NMR relaxometer.
The magnetic field was approximately 0.1 T; the operating frequency of the device was 4.317 MHz.
The relative inhomogeneity of the magnetic field in the operating volume of the magnetic system
(diameter of 10 mm and height of 10 mm) did not exceed 10−4. The spin-spin relaxation time (T2) was
measured using the Carr–Purcell–Meiboom–Gill (CPMG) pulse sequence with echo spacing TE = 1 ms.
Serial 10-fold dilutions of the magnetic nanoclusters were prepared. The starting concentration of the
magnetic nanoclusters was approximately 0.02–0.03 mg/mL. After dilution, the nanocluster suspension
was sonicated for 10 s (an immersion-type probe was used). Then, 100 µL of suspension was placed
in a clean well of a 96-well culture plate (Thermo Fischer Scientific). The cell was placed in an axial
measuring coil of the relaxometer. A linear relationship between relaxivity and the concentration of
nanoclusters indicated the absence of agglomeration during the measurement.
3. Results and Discussion
3.1. Influence of pH, Ionic Strength, and Protein-to-Nanoparticle Ratio on the Size of Protein-Coated Nanoclusters
Conjugates of magnetic nanoparticles with proteins were synthesized using the following
strategy. Fe@C Powder with a mean size of approximately 6 nm [33] was aminated. The aminated
iron-carbon nanoparticles (Fe@C-NH2) were added to aqueous protein solutions. Two simultaneous
processes occurred: a pH-dependent aggregation of Fe@C-NH2 and stabilization of aggregates by
protein molecules (Fe@C-NH2/Protein). The formed surface protein layer was cross-linked with
glutaraldehyde and then desired recognition molecules: streptavidin (Fe@C-NH2/Protein/Str) or
protein G (Fe@C-NH2/Protein/G) was attached via the reaction of primary amines with carbonyl groups
(Figure 1). It should be noted that cross-linking stabilizes nanoclusters, and their size depends only on
the coating conditions.
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Figure 1. Synthesis of Fe@C-NH2/Protein/Str and Fe@C-NH2/Protein/G. 4-ABA-4-aminobenzylamine.
In our previous study, we demonstrated that variations in pH could be applied to tune the size of
BSA-coated nanoclusters [33]. Here, we investigated the influence of coating conditions (pH, ionic
strength, protein-to-nanoparticle mass ratio and sonication time) on the interaction between different
proteins (casein, BSA, and gelatins) and Fe@C-NH2 to obtain protein-coated nanoclusters of the desired
size. Aminated nanoparticles were coated with proteins under a variety of conditions: pH ranging
from 4 to 9, ionic strength ranged from 0.01 to 0.5, and protein-to-nanoparticle mass ratios from 10:1
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to 1.25:1. The size of nanoclusters was measured in PBS after the glutaraldehyde cross-linking of the
protein layer.
In our experiments, the size of nanoclusters resulted from a trade-off between the aggregation of
Fe@C-NH2 at pH > 4 and the protein stabilization of Fe@C-NH2 aggregates. Fe@C-NH2 is stable at
pH 4 [33] (see the zeta potential of Fe@C-NH2 in Figure S2) and aggregates slowly at pH 5 and 9, while
at neutral pH, immediate aggregation occurs. Generally, a slight increase in size was observed when the
coating was performed at pH 6–8; this effect was more pronounced for gelatin B (Figures S3–S6). At high
ionic strength, only the highest protein-to-nanoparticle ratios provided stability to the nanocomposites
at pH between 6 and 8. The increase in ionic strength led to the overall growth of the nanoclusters’
size and polydispersity. Interestingly, in comparison with BSA and especially casein, the gelatin B
coating efficiently stabilized nanoclusters, even at the highest salt concentration, without a sharp
increase in the mean diameter. In total, a decrease in the protein-to-nanoparticle mass ratio caused the
enlargement of the nanoclusters, especially when BSA was used. It is known that van der Waals forces,
hydrogen bonding, Coulombic forces, and hydrophobic interactions are the main driving mechanisms
of protein adsorption on nanoparticles [34]. Apparently, Coulombic forces possess a dominant role
in the stabilization of Fe@C-NH2 by casein, because this protein provides good stability in solutions
with lower salt concentrations. In contrast, the impact of the hydrophobic force prevails in the case of
gelatin B. Gelatin A showed a poor ability to stabilize aminated nanoparticles even at the lowest ionic
strength. Therefore, media with higher salt concentrations were not tested.
Sonication power is another parameter that can be used to manipulate the size of protein-coated
nanoparticles [35]. Prolonged sonication allows up to a two-fold decrease in particles’ size and
polydispersity (Figure S7).
In further experiments, we adjusted the synthesis conditions to obtain protein-coated magnetic
nanoclusters with various sizes to explore their stability, relaxivity, and functional activity in the solid
phase NMR-assay.
3.2. Synthesis and Relaxivity Study of Protein-Coated Nanoclusters with Tunable Size
The size of magnetic nanoparticles affects their r2 relaxivity [13] and may be critical for different
aspects of immunoassays. Wang et al. demonstrated that the migration rate of magnetic nanoparticles
inside the lateral flow test strip depends on their diameter, and in turn, has a dramatic impact
on the assay duration and sensitivity [36]; furthermore, smaller magnetic nanoparticles provide a
more efficient magnet-assisted pre-analytical enrichment of samples [3]. The application of larger
nanoparticles and even microparticles in homogeneous NMR sensors can improve the lower limit of
detection [37].
We prepared nanoclusters of iron-carbon magnetic nanoparticles coated with casein, BSA and
gelatin B and conjugated with streptavidin. For each type of coating, three groups of conjugates were
obtained: “small”, “medium”, and “large”. We should note that the size of each group depended on
the coating type, e.g., we were unable to prepare Fe@C-NH2/Gelatin B/Str with a diameter less than
140 nm; at the same time, 100–110 nm nanoclusters can be easily obtained when the BSA coating is used.
Despite the difference in absolute diameters, both conjugates were designated as “small”. Moreover,
various streptavidin-to-nanoparticle ratios were used for all groups: from 10:1 to 160:1 (µg:mg), and in
total, 45 conjugates were prepared. The main characteristics of conjugates are summarized in Table 1.
Detailed information about the size, polydispersity, and zeta potential of each synthesized conjugate
can be found in Figures S8, S9 and Table S1. The size of Fe@C-NH2/Protein/Str was measured by
DLS, while the migration of nanoclusters in agarose gel was used to characterize and compare the
nanoclusters (Figure S10, lanes 1, 6–14). The mobility of nanoclusters depends on their size and zeta
potential; the nanocluster migration pattern confirms the results of DLS: casein- and BSA-coated
nanoclusters with the highest zeta potentials moved strongly toward the positive electrode. “Large”
nanoclusters hardly entered the gel, even 30 min after the start.
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Table 1. Properties of conjugates prepared during size-tuning experiments.
Coating Fe@C-NH2/BSA/Str Fe@C-NH2/Casein/Str Fe@C-NH2/Gelatin B/Str
Group “Small” “Medium” “Large” “Small” “Medium” “Large” “Small” “Medium” “Large”
Dh, nm 114–121 172–186 211–233 114–131 194–198 235–274 142–160 212–243 279–309
PdI 0.188–0.208 0.158–0.175 0.247–0.258 0.178–0.201 0.132–0.169 0.202–0.243 0.211–0.248 0.200–0.260 0.227–0.257
Zeta potential, mv −24–−25 −23–−25 −24–−25 −25–−27 −25–−26 −24–−26 −10–−12 −9–−10 −9–−10
Relaxivity, 1/mM−1 × s−1 234–265 262–322 186–230 310–354 318–340 303–345 266–306 296–377 282–324
Note: Severe aggregation was observed in the conjugate Fe@C-NH2/Gelatin B/Str synthesized at a streptavidin-to-
nanocluster ratio of 10:1 immediately after the synthesis, and this conjugate was excluded from our study.
Interestingly, large nanoclusters can be seen in the wells in which “medium” nanoclusters were
loaded (Figure S10, lanes 6, 10, and 13). Moreover, “medium” nanoclusters distributed more diffusely
along the path of migration compared with that of “small” nanoclusters, indicating the presence
of a portion of large nanoclusters, and hence, a high polydispersity. However, according to DLS,
the “medium” nanoclusters possess the lowest polydispersity. Moreover, it is well known that DLS
overestimates the hydrodynamic diameter and shows a high polydispersity when large aggregates
are present in the sample. A possible explanation is that nanoclusters larger than 170–180 nm do not
enter the gel, while the smaller ones penetrate it. A diffuse band of nanoclusters represents those
with a size between 130 and 170 nm, which are also present in the samples. Coomassie Blue staining
of the protein-coated nanoclusters after gel-electrophoresis was performed to confirm the presence
of a protein on the surface of Fe@C-NH2; unfortunately, the nanoclusters are too dark to detect any
color change.
The functional activity of each Fe@C-NH2/protein/Str conjugate was examined in the solid phase
NMR-assay. Biotinylated BSA was spotted on nitrocellulose test-strips in 10-fold dilutions, then, diluted
conjugates were added, and the relaxation time depending on the number of nanoclusters attached to
nitrocellulose was measured (Figure S11). Thus, we confirmed the applicability of the synthesized
nanoclusters for NMR-assays; calibration curves were obtained for each conjugate (Figure S12).
The type of coating, size of nanoclusters, and streptavidin-to-nanocluster ratio had a negligible effect
on the shape of the calibration curves.
The protein coating of the magnetic nanoparticles can enhance their r2 relaxivity [13]. Recently,
this effect was demonstrated for casein [38] and BSA [39,40]. Inspired by the above, we studied the r2
relaxivity of Fe@C-NH2/Protein/Str of different sizes. The relaxivity values of Fe@C-NH2/Casein/Str
and Fe@C-NH2/Gelatin B/Str are independent of their size and are higher in comparison with
that of Fe@C-NH2/BSA/Str (Figure 2). Moreover, the r2 relaxivity of Fe@C-NH2/BSA/Str was
even lower than that of the parent Fe@C-NH2. We suggested that the different structures of the
Fe@C-NH2/Protein/Str nanoclusters can be the reason for the differences in their r2 relaxivity values.
The study of Fe@C-NH2/Protein/Str using transmission electron microscopy showed that individual
Fe@C-NH2 particles are more uniformly distributed (Figure 3a) in the Fe@C-NH2/Casein/Str in
comparison with Fe@C-NH2/Gelatin B/Str (Figure 3c) and especially Fe@C-NH2/BSA/Str (Figure 3b).
Therefore, we suggest that the uniformity of the Fe@C-NH2 nanoparticle distribution inside the
nanocluster, rather than the size of the Fe@C-NH2/Protein/Str nanocluster, affects the nanoclusters’ r2
relaxivity. Roca et al. [41] noted that the influence of magnetic nanoparticles on the proton relaxation
rate is determined by not only the properties of an individual particle (saturation magnetization,
nanoparticle size) but also how the magnetic nanoparticles are distributed inside their agglomerate.
This effect is because the agglomerates of nanoparticles located inside the conjugate will be inaccessible
to protons. In contrast, a uniform distribution of noninteracting magnetic nanoparticles inside a protein
conjugate will make the greatest contribution to relaxation, provided that the medium separating them
(in our case, protein) is permeable to protons.
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Thus, Fe@C-NH2 nanoparticles are distributed nonuniformly in the protein matrix, affecting the
Fe@C-NH2/Protein/Str relaxivity. The uniformity of distribution, in turn, depends on the nature of the
protein and the procedure for the synthesis of Fe@C-NH2/Protein/Str. It should be noted that despite
the Fe@C-NH2/Protein/Str from each size group (“small”, “medium”, and “large”) being prepared
using the same portion of Fe@C-NH2/Protein, the resulting relaxivity varied significantly (in the range
of 80 1/mM−1 × s−1) between conjugates from the same size groups (Table 1, Table S1), reflecting the
significant influence of fluctuations in the synthesis procedure on relaxivity. A further increase in
the relaxation characteristics can be achieved by selecting such synthesis conditions that ensure the
uniform distribution of individual nanoparticles in the protein shell and prevent the formation of their
aggregates. It must be emphasized that the relaxivity of the synthesized nanoconjugates is comparable
to the relaxivity of MRI contrasts based on iron oxides [23].
3.3. Characterization of Nanoclusters
Th structure and morphology of nanoclusters were assess d u ing atomic force microscopy
(AFM) and TEM. As shown in Figure 4a–d, Fe@C-NH2/Protein/Str has a ne rly round shape. We did
not a sess the m an size of conjugates by microscopy because aggregat wer produced during the
sample preparation. The mean hydrodynamic diameters (intensity of the main peak) were determined
by DLS, and they are reported throughout the article. The presence f proteins on the surface of
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Fe@C-NH2/Protein/Str and Fe@C-NH2/protein/G was confirmed by UV-VIS spectroscopy; there is a
pronounced peak at 190–250 nm, indicating the successful functionalization (Figure 4f–i).
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reflects the efficiency of the vaccination. According to the World Health Organization, the protective 
threshold of antitoxin concentration is 0.1 IU/mL [42]. Nitrocellulose test-strips were coated with 
Figure 4. Properties of nanoclusters coated with different proteins. Upper left: atomic force microscopy
(AFM) images of nanoclusters coated with different proteins: (a) BSA, (b) casein, (c) gelatin A,
and (d) gelatin B; lower left: (e) thermogravimetric analysis (TGA) curves of Fe@C-NH2, BSA and
Fe@C-NH2/BSA/Str in airflow; upper right: UV-Vis spectra of Fe@C-NH2, Fe@C-NH2/Protein/Str and
proteins: (f) BSA, (g) casein, (h) gelatin B, and (i) gelatin A; and lower right: (j) stability of Fe@C,
Fe@C-NH2, Fe@C-NH2/Gelatin B/Str in buffers with pH 4 and 7.
Moreover, the changes in electrophoretic mobility (Figure S10, lanes 1–5) and dispersibility
at different pH (Figure 4j) also prove the presence of the protein coating. Aminated iron-carbon
nanoparticles immediately ag regate in the electrophoresis buffer, while the protein-coated nanoclusters
enter the gel an move toward the p sitive electrode. Fe@C s dimented at pH 4 a d 7, the F @C-NH2
a stable at pH 4 because of the electr stati repulsion between protonated amino groups, but this is
not the case at pH 7. Gelati -coated nanoclusters are stable at both pH 4 and 7, and this is opposite to
the behavior of casein- and BSA-coated ones, whose size remains unchanged at pH 7 but slowly grows
at pH 4 (see Section 3.6).
Thermogravimetric analysis (TGA) was used to determine the concentration of Fe in Fe@C-NH2 and
confirm the presence of a protein coating. The TGA curves of Fe@C-NH2, BSA, and Fe@C-NH2/BSA/Str
(Figure 4e) showed that below 180 ◦C the weight loss of all samples was quite small (5–7%) because of
the removal of physically and chemically adsorbed water. In the segment from 190 to 330 ◦C, the TGA
curve of Fe@C-NH2 exhibits a gradual weight gain. This weight gain implies that the Fe cores are being
slowly oxidized. The data also indicate that Fe@C nanoparticles are securely stable below 190 ◦C in air.
Above 330 ◦C, the full oxidation to Fe2O3 occurs, and the weight loss neglects the weight gain due
to the oxidation of carbon to CO2. That is, the weight loss between 330 and 800 ◦C is recognized as an
active chemical reaction in which the graphite phase is oxidized to CO2 gas. The oxidation temperature
of the carbon shell in the Fe@C-NH2 nanoparticles is significantly lower than that of carbon nanotubes
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(527–727 ◦C) and bulk graphite crystals (846 ◦C); this outcome is ascribed to a mass of lattice defects
resulting from the serious bending of the graphite atomic layers. From the TGA data, we calculate that
the concentration of the magnetic Fe in a Fe@C-NH2 sample is 68.1 wt%. In contrast to Fe@C-NH2,
there was no weight gain when the Fe@C-NH2/BSA/Str nanoclusters were analyzed, evidently due to
the presence of the protein coating. The complete degradation of BSA took place in the range from 200
to 640 ◦C, and only Fe2O3 remained in the crucible after 650 ◦C. We calculated that the concentrations
of magnetic Fe and BSA in the Fe@C-NH2/BSA/Str nanoclusters were 45.7 and 31.5 wt%, respectively.
3.4. NMR-Assay of Anti-Tetanus Antibodies
The protein-coated magnetic nanoclusters were applied to the solid phase NMR-assay of
anti-tetanus antibodies. The concentration of antibodies correlates with the protection against
tetanus and reflects the efficiency of the vaccination. According to the World Health Organization,
the protective threshold of antitoxin concentration is 0.1 IU/mL [42]. Nitrocellulose test-strips were
coated with tetanus toxoid and then treated with antibodies against tetanus toxoid. The antibodies
were detected with protein G-conjugated magnetic nanoclusters, which decrease the relaxation of
water protons inside the pores of the membrane. Thus, the T2 relaxation time of water protons is
proportional to the antibody concentration (Figure 5).
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(NMR)-immunoassay of I G against the anti-tetanus toxoid. (a) the principle of the assay; (b) day-to-day
variability of the anti-T NMR-as ay; (c) dose-res t i ed using Fe@C-NH2/Casein/G;
(d) NMR-relaxometer and sample ho der (inset): 1—magnet, 2—sample holder, 3—NMR-relaxometer,
4—radio-frequency coil, and 5—test-strip in pla ic envelope.
Regardless of the material used to coat nanoclusters, they were applicable for antibody detection.
Fe@C-NH2/BSA/G and Fe@C-NH2/Casein/G provided better analytical sensitivities; however, lower
nonsp cific signals and steeper slopes of dos -response curves were generated for gelatin-coated
nanoclusters (Figure S13). We did not optimize the assay condition but rather used the same assay
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parameters for all four tested conjugates, and there are clear differences in their performances. Generally,
good day-to-day reproducibility of the analysis was obtained for all conjugates. However, significant
variation was observed in the blank sample for Fe@C-NH2/Gelatin A/G (Figure S13). To assess whether
the antibody in real samples can be detected, we tested 10 blood serum samples obtained from
vaccinated individuals. Fe@C-NH2/Casein/G was used in the assay. The lower limit of detection
was 0.52 mIU/mL (blank + 3 SD), which is less than that of double-antigen ELISA or bead-based
multiplex immunoassay (Table 2). Nevertheless, analytical sensitivity of the assay was far less than
the protective threshold and allows quantification of anti-TT IgG in unprotected individuals. A good
correlation (r2 = 0.97) with the ELISA results was demonstrated. However, the NMR-assay significantly
overestimated antibody concentrations, indicating that further optimization is necessary (Figure S14).
Table 2. Comparison of the NMR-assay with anti-TT IgG detection methods described in literature.
Assay Label LOD, mIU/mL Assay duration, h Reference
ELISA horseradish peroxidase 0.01 4 [43]
Multiplex immunoassay fluorescent beads 0.01 1.25 [44]
Lateral flow assay gold nanoparticles 10 0.25 [45]
Surface plasmon resonance assay gold nanoparticles 5 2.15 [46]
ELISA on polymer fibers horseradish peroxidase 0.5 2.15 [47]
Microfluidic assay fluorescent dye 100 Less than 1 [48]
NMR assay carbon-coated ironnanoparticles 0.52 3–4 This work
3.5. Thermal Stability Study
The colloidal stability of magnetic nanoprobes at elevated temperatures is essential for applications
in assays based on the isothermal amplification of DNA (e.g., loop-mediated isothermal amplification
or rolling circle amplification) [49] or PCR [50], when reaction mixtures can be heated up to +95 ◦C.
The aggregation of nanoparticles can negatively influence assay performance. Herein, we tested how
heating affects the size of protein-coated nanoclusters. The interaction with the nanoparticles and
cross-linking enhance the heat stability of proteins [51,52], and vice versa, where protein coatings can
protect nanoparticles from heat-induced aggregation [53].
The size of Fe@C-NH2/BSA/G was almost the same until +80 ◦C; from +80 to +100 ◦C, the
nanoparticle diameter sharply increased (Figure 6). Meanwhile, the diameter of Fe@C-NH2/Casein/G
gradually increased from 132 to 144 nm, but the polydispersity indices of both conjugates did not exceed
0.2, reflecting good thermal stability. According to [54], irreversible heat denaturation of BSA starts at
+50 ◦C and becomes more prominent with increasing temperature; in contrast, casein is an intrinsically
unstructured protein with a better heat stability [55]. These differences can explain the nanoclusters’
behaviors upon heating. The hydrodynamic diameter of gelatin-B-coated nanoclusters did not change
significantly. However, the polydispersity index increased at temperatures of +70 ◦C and higher.
The increase in the polydispersity of Fe@C-NH2/Gelatin A/G occurred at +60 ◦C and higher. These
data are in agreement with the findings of Bigi et al., demonstrating the denaturation of glutaraldehyde
cross-linked gelatin gels at +70 ◦C [51]. In total, the thermal stability of protein-coated nanoclusters
is appropriate for the application in homogeneous assays, which require heating. The nanoparticle
size increase of 10–30 nm should not significantly influence the surface-to-volume ratio and relaxivity,
especially for the casein and gelatin coatings (see Section 3.2).
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A resistance to aggregation is an inevitable requirement of nanoconjugates that is necessary
for their practical implementation. Nanop rticles should be stable at eutral and near-n utral pH
to be suitable for most of bi analytical applicati ns. Moreov r, for some applic tions, a stability at
extreme pH or ionic strength, t least short-term, is much needed. Herein, we directly compared the
hydrody amic diameter and polydisp sity of agnetic nanoclust rs coate with BSA, casein, and
gelatins A and B fter 1 and 24 h of incubation in buffers with pH 4–10 and a salt concentr tio from
0.15 to 2 M. Two different methods were used: dynamic ligh scattering T2 relaxometry. The latter
is sensitive to the size of the magnetic nanoclusters because their aggregatio results in the growth of
T2. This method is semiquantitative r ther than quanti ative and was only applied to strengthen t e
resul s obtained u ing DLS.
Nanoparticles coated with BSA and casein were stable in solutions at pH 6–10 when the ionic strength
did not exceed 0.5 M; however, aggreg tion was observed t pH 6 in 2 M PBS. A slight growth in the size
of casein-coated nanoclusters can be seen after 24 h of incubation. This growth was more prominent in
2 M solutions, where nanocluster e l rgement occurred ven a alkaline pH. Imp rtantly, there was no
significant aggregation of ge atin-coated nanoclusters at any pH or io ic strength after 24 h. The i crease
in ionic strength from 0.15 to 2 M resulted in the verall growth f the ’ di meter to approx.
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m asuremen s. Three technical re licates were prepared for each sample, and in some cases, a significant
discrepancy between replicates was observ d. Repeated measur ments of the s me cuv tte som times
gave opposing results (low/high polydispersity). Moreover, som times a dramatic decrease in size an
polydispersity was observed for repeated measurements of the sam replicate after 24 h of incubation,
which is hardly possible. For these reasons, we excluded unreproducible results from the analysis use
to prepare the graphs (Figure 7). Furthermore, the short-term stability of conjugate under the same
conditions was assessed by T2 relaxometry (Figure 8). The results of the T2 measurements confirmed the
previous findings. A significant increase in T2 was ob erved af er the incubation f BSA- and casein-coated
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Fe@C-NH2 in buffers with acidic pH. The increase in T2 for casein-coated nanoclusters after 24 h was
more prominent than that for Fe@C-NH2/BSA/G, especially in solutions with ionic strengths higher than
0.5 M. The T2 relaxometry was not sensitive enough to distinguish between the mentioned 20–30 nm
size differences caused by the high salt concentration. However, a slight increase in T2 was found for
gelatin-coated nanoclusters diluted in buffers with pH 4 and ionic strengths of 0.15 and 0.5 M, but not of
2 M. Some degree of aggregation of nanoclusters coated with gelatins A and B probably takes place at this
pH, but we did not reveal it by DLS.
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coated magnetic nanoclusters were almost insensitive to pH variations in the range from 4 to 10, and 
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proteins. Notably, such behaviors correspond with the zeta potential variations: the zeta potentials 
of Fe@C-NH2/BSA/G and Fe@C-NH2/Casein/G are between 0 and −20 mV at pH 4 and 5 (Figure 8). 
Surprisingly, there is no such distinct relationship between the zeta potential of gelatin-coated Fe@C-
NH2 and its aggregation state. Moreover, despite the zeta potentials of both Fe@C-NH2/Gelatin A/G 
and Fe@C-NH2/Gelatin B/G being very low in comparison with the widely accepted ±30 mV stability 
threshold, they withstand aggregation, even at high ionic strengths, indicating the more significant 
role of hydration forces [68] and steric rather than the electrostatic repulsion between gelatin-coated 
nanoparticles [69]. Casein-coated nanoclusters are more sensitive to the increase in salt concentration. 
Therefore, we suppose that mainly the surface charge provides stability to these nanoclusters. 
Figure 7. Colloidal stability of Fe@C-NH2/Protein/G in buffers with different pH and ionic strength
values. Ionic strength values are specified at the top of the figure. “BSA”, “Casein”, “Gel B”, and “Gel
A” indicate coating protein. Blue line—hydrodynamic diameter at 0 (dashed line) and 24 h (solid line);
orange line—polydispersity index at 0 (dashed line) and 24 h (solid line), n = 3, mean ± SD.
Our observations are in contradiction with the findings of [56], who demonstrated the aggregation
of glutaraldehyde cross-linked gelatin nanoparticles at pH 5. At the same time, Gaihre et al. [57] and
Sivera et al. [58] respectfully obtained suspensions of Fe3O4 and Ag nanoparticles coated with gelatin
that were stable at a pH range of 2–12. Gaihre et al. synthesized gelatin A- and gelatin B-coated
iron oxi e nanoparticles that were stable at pH 4–8. A slight sedimentation was observed for gelatin
B-encapsulated nanoparticles but not for gelatin A-encapsulated nanoparticles at ionic strengths higher
than 0.1. This result was explained by the more prominent “salting out” of the former provoked by
more gelatin B adsorbed on iron oxide nanoparticles [59]. Furthermore, a gelatin A coating prevented
gold nanoparticles from aggregation at high ionic strengths [60].
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Several research groups also studied the stability of casein- and BSA-functionalized nanoparticles.
Casein-encapsulated iron oxide nanoparticles were stable at pH 2–8 except for pH 4 [61]. Casein-coated
zein nanoparticles were stable at I 0–200 mM and pH 2–9. However, a growth in diameter at pH 4
and 5 was observed [62]. A severe aggregation of casein-coated Ag nanoparticles was observed at
pH lower than the isoelectric point of casein; however, this was not so at pH 8–13, and only a slight
aggregation was observed at pH lower than 8. While, salt concentrations up to 0.5 M did not induce a
change in their size [63]. BSA-coated quantum dot/magnetic nanoparticle composites were stable at
ionic strengths up to 0.5 and at pH 5–13 but aggregated at pH 3 and 4 [64]. Zhang et al. demonstrated
the good stability of quantum dots coated with BSA at ionic strengths up to 2 M and at pH ranging
from 2–12 with small decreases at 5.6 and 6.1 [65]. BSA-coated magnetic nanoparticles were stable at
pH 4–13 except for pH 5.6 and at an ionic strength from 10 mM to 1 M [66]. Gold nanoparticles with a
BSA shell were also stable throughout pH 1.5–10 except at pH near 4.5–5 [67].
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Figure 8. The T2 relaxation times of Fe@C-NH2/Protein/G diluted in buffers with different pH and
ionic strength values and the zeta potentials of Fe@C-NH2/Protein/G. “BSA”, “Casein”, “Gel B”, and
“Gel A” indicate coating protein. T2 in 0.15 M (red line), 0.5 M (green line), and 2 M (blue line) buffers
at 0 (dashed line) and 24 h (solid line), n = 3, mean ± SD.
We can conclude that our results are consistent with those of previous studies; however, a
direct comparison is complicated because of the different functionalization strategies. In our study,
gelatin-coated magnetic nanoclusters were almost insensitive to pH variations in the range from 4
to 10, and BSA- and casein-coated nanoclusters aggregated at pH values near the isoelectric points
of these proteins. Notably, such behaviors correspond with the zeta potential variations: the zeta
potentials of Fe@C-NH2/BSA/G and Fe@C-NH2/Casein/G are between 0 and −20 mV at pH 4 and 5
(Figure 8). Surprisingly, there is no such distinct relationship between the zeta potential of gelatin-coated
Fe@C-NH2 and its aggregation state. Moreover, despite the zeta potentials of both Fe@C-NH2/Gelatin
A/G and Fe@C-NH2/Gelatin B/G being very low in comparison with the widely accepted ±30 mV
stability threshold, they withstand aggregation, even at high ionic strengths, indicating the more
significant role of hydration forces [68] and steric rather than the electrostatic repulsion between
gelatin-coated nanoparticles [69]. Casein-coated nanoclusters are more sensitive to the increase
in salt concentration. Therefore, we suppose that mainly the surface charge provides stability to
these nanoclusters.
3.7. Storage Stability
The practical impl mentation of nan particle-based diagnostic reagents requires them to be stable
for extended periods [70]. We moni the size and polydispersity of Fe@C-NH2/Prot in/G, which
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was stored at +4 and +37 ◦C for four weeks. A temperature range from +2 to +8 ◦C is widely used
for the storage of bioreagents, including test kits and diagnostic reagents (e.g., enzyme conjugates).
The exposure of components of test kits to elevated temperatures is a rapid and efficient way to assess
their long-term stability. According to [71], seven days at +37 ◦C is equivalent to one year at +4 ◦C.
Apparently, this approximation applies mainly to proteinaceous reagents, which are liable to thermal
denaturation. However, nanoparticles aimed for use in in vivo applications are also tested under
accelerated conditions [72].
The hydrodynamic diameter and polydispersity of protein-coated nanoclusters did not alter
after one month of the storage. The most notable change was observed for Fe@C-NH2/Casein/G
stored at +4 ◦C, in which the size was increased from 128 to 142 nm (Figure 9). At the same time,
elevated temperatures did not affect the size of this conjugate. Therefore, the growth of nanoclusters at
+4 ◦C was rather due to the variability in the measurements. To reinforce these results, we assessed
the diameter and polydispersity alterations of the nanoclusters obtained during the course of the
size-tuning experiments, which were stored for four months (Figure S15). Generally, there were no
systematic changes in the hydrodynamic diameters. A time-dependent size alteration in some samples
(denoted with arrows in Figure S15) can be attributed mainly to the variability of the DLS method
because not only increases but also decreases in the mean diameter after storage were observed.
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the three bars represent T2 at 0, 1, and 5 h (from left to right). 
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Plasma and serum are among the most significant specimens in clinical diagnostics; milk, juice, beer, 
and wine are popular foods that are usually tested for the presence of pathogens and their toxins 
before becoming available to consumers. The tested media do not contain any magnetic material, and 
hence, do not affect the results of the T2 relaxometry, which depends only on the aggregation of 
magnetic nanoparticles diluted in these media [74]. Most of the nanoparticle-based assays require 
only minutes- to hours-long incubations of nanoprobes in the samples under study. Therefore, we 
assessed the T2 change of diluted nanoclusters after 1 and 5 h of incubation. 
There was no significant change in T2 after the incubation of casein- and BSA-coated 
nanoclusters in juice, milk, and blood serum/plasma. An increase in T2 was observed for all four 
types of nanoclusters diluted in beer. However, for Fe@C-NH2/BSA/G and Fe@C-NH2/Casein/G, a 
sharp increase in T2 was observed for the gelatin-coated nanoclusters after dilution in serum and 
Figure 9. Storage stability of Fe@C-NH2/Protein/G and stability of Fe@C-NH2/Protein/G and
Fe@C-NH2/Protein/Str in complex media. Upper row: changes in hydrodynamic diameter (a) and
polydispersity index (b) during four weeks of storage at different temperatures; the five bars represent
the size or PdI at week 0, 1, 2, 3, and 4 (from left to right), statistics: two-way ANOVA with Dunnet’s
post-hoc test, n= 3, mean± SD; lower row: the T2 of Fe@C-NH2/Protein/G (c) and Fe@C-NH2/Protein/Str
(d) diluted in juice (J), wine (W), beer (B), milk (M), blood serum (S), and plasma (P); the three bars
represent T2 at 0, 1, and 5 h (from left to right).
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3.8. Stability of Nanoclusters in Complex Media
Magnetic nanoparticles are widely used in the homogeneous assays of pathogens, toxins, heavy
metals, and other analytes in food, physiological, and environmental samples. In the course of
these assays, the nanoparticles encounter a complex mixture of proteins, carbohydrates, lipids, and
their complexes, which can induce nanoparticle aggregation and the subsequent loss of functions.
The nonspecific aggregation of nanoparticles is undesirable for aggregation-based assays (e.g., T2
relaxometry) because it leads to false-positive results. Moreover, the aggregation of nanoparticles
can reduce the efficiency of the magnetic enrichment [73]. We studied the stability of protein-coated
nanoclusters in blood serum/plasma, orange juice, milk, red wine, and beer by T2 relaxometry. Plasma
and serum are among the most significant specimens in clinical diagnostics; milk, juice, beer, and
wine are popular foods that are usually tested for the presence of pathogens and their toxins before
becoming available to consumers. The tested media do not contain any magnetic material, and hence,
do not affect the results of the T2 relaxometry, which depends only on the aggregation of magnetic
nanoparticles diluted in these media [74]. Most of the nanoparticle-based assays require only minutes-
to hours-long incubations of nanoprobes in the samples under study. Therefore, we assessed the T2
change of diluted nanoclusters after 1 and 5 h of incubation.
There was no significant change in T2 after the incubation of casein- and BSA-coated nanoclusters
in juice, milk, and blood serum/plasma. An increase in T2 was observed for all four types of nanoclusters
diluted in beer. However, for Fe@C-NH2/BSA/G and Fe@C-NH2/Casein/G, a sharp increase in T2 was
observed for the gelatin-coated nanoclusters after dilution in serum and plasma. Moreover, aggregates
of gelatin-encapsulated nanoclusters in blood samples were visible by the naked eye. The aggregation
of gelatin-coated nanoclusters was not associated with the interaction between protein G and the IgG
from the plasma/serum because the experiment with Fe@C-NH2/Protein/Str produced the same result
(Figure 9). All tested conjugates were aggregated in red wine. The complex relationship between the
size and surface structure of nanoparticles and their relaxivity is well known [13]. Thus, we cannot
fully explain the alteration of T2 in each case. Nevertheless, the aggregation of nanoclusters and
adsorption of the media’s components on their surface definitely have a significant impact. According
to the obtained results, we can conclude that gelatin-coated nanoclusters are inappropriate for the
determination of analytes both in undiluted serum and plasma. All four conjugates can be added to
whole milk and juice.
3.9. Protein Corona
The blood serum composition represents a variety of pathological and physiological processes that
makes serum one of the most informative and important clinical specimens. Nonspecific interactions
of nanoparticles with serum components are inevitable when their mixing takes place during the assay
procedure. Matrix interference is a significant issue in magnetic nanoparticle-based biosensing, causing
a dramatic decrease in specificity [75]. According to recent reports, protein shells can provide antifouling
properties by decreasing the amount of nonspecific binding of cells and medium components, first
of all, serum proteins [65,76,77]. At the same time, the coating of nanoparticles with biocompatible
natural polymers can increase the nonspecific protein binding [78]. Herein, we assessed the adsorption
of serum proteins on the surface of Fe@C-NH2/Protein/Str by SDS-PAGE and Bradford assays.
Different protein coronas are formed after the incubation of nanoclusters in serum and plasma
(Figure 10 and Figure S16). The overall amount of adsorbed protein from blood serum was the same for
both coated nanoclusters and parent uncoated nanoparticles (Fe@C-NH2) except for Fe@C-NH2/Gelatin
A/Str, which was bound with twice as much protein. However, we should note that direct comparisons
of protein binding capacity are not completely correct because protein quantification by Coomassie
staining depends on the amino acid composition of the protein under study. We find explaining the
increased serum protein binding by gelatin-A-coated nanoclusters to be quite challenging, especially
in the light of the fact that gelatins A and B have the same protein binding pattern and that the protein
bands in stained gels have the same intensity. Moreover, according to SDS-PAGE, a significantly higher
Nanomaterials 2019, 9, 1345 20 of 26
adsorption of plasma proteins by Fe@C-NH2/Gelatin B/Str was revealed (Figure 10). The protein
coating did not reduce the nonspecific binding of serum proteins but rather led to a change in the
composition of the protein corona. This fact corresponds with the results of Mirshafiee et al., who
demonstrated that proteins could promote the adsorption of certain groups of serum proteins and
reduce the adsorption of others in comparison with uncoated nanoparticles [79]. Additionally, smaller
nanoparticles bind less protein from serum/plasma both per nanoparticle [80] and per unit area [81].
Uncoated Fe@C-NH2 nanoparticles have the lowest hydrodynamic diameter; however, they rapidly
aggregate upon mixing with serum, and an accurate determination of their diameter is complicated.
Gelatin A-coated nanoclusters are the largest one, but their size is only 30 nm larger than that of
Fe@C-NH2/Gelatin B/Str (186 nm vs. 154 nm). At the same time, Fe@C-NH2/BSA/Str (111 nm) and
Fe@C-NH2/Casein/Str (119 nm) are approximately 30–40 nm smaller than Fe@C-NH2/Gelatin B/Str, but
they all adsorb the same amount of protein.Nanom terials 2019, 9, x FOR PEER REVIEW 21 of 27 
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protein markers (kDa). (b) The sorption of serum proteins on Fe@C-NH2/Protein/Str and Fe@C-NH2. 
(d) The size of Fe@C-NH2/Protein/Str after incubation in the trypsin solution (dashed line, filled 
circles) or PBS (solid line, open circles). Coating: BSA (red), casein (yellow), gelatin A (green) and B 
(blue), n = 3, mean ± SD. 
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NH2/Protein/Str size was monitored within 24 h. We used trypsin at high concentration (100 μg/mL), 
similar to that of the intestinal secretion of a human adult (approx. 100–500 μg/mL) [83], to provide 
an accelerated study. 
An almost two-fold drop in the mean diameter of gelatin-coated nanoclusters was observed after 
1 h of incubation (Figure 10) without further changes. Conversely, only a slight decrease in BSA- and 
casein-coated nanocluster diameters occurred. After 24 h of agitation at +37 °C, the size of the 
nanoclusters increased in the control samples (without trypsin) but not in the test samples. In the 
previous sections, we noted that all conjugates were stable to heating; however, in this experiment, 
highly diluted (10 μg/mL) suspensions were used without the addition of stabilizers including BSA, 
glycerol, and glycine. These results demonstrate that stabilizers are essential for the preservation of 
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Figure 10. Protein corona a d stability of nanoclusters to proteolysis. Pr tein coronas of Fe@C-NH2/BSA/Str
(lane 2), Fe@C-NH2/Casein/Str (lane 3), Fe@C-NH2/Gelatin A/Str (lan 4), Fe@C-NH2/Gelatin B/Str
(lane 5), and Fe@C-NH2 (lane 6) in blood serum (a) and plasma c , with lane 1-protein markers
(kDa). (b) The sorption of serum protei s on Fe@C-NH2/Protein/Str and Fe@C-NH2. (d) The size of
Fe@C-NH2/Protein/Str after incubation in the trypsin solution (dashed line, filled circles) or PBS (solid line,
open circles). Coating: BSA (red), casein (yellow), gelatin A (green) and B (blue), n = 3, mean ± SD.
3.10. The Resistance of Nanoclusters to Proteolysis
Proteolytic cleavage by proteases from the environment reduces the shelf-life of proteins and their
conjugates [82]. To assess the impact of protease digesti on the structural int grity f protei -coated
Nanomaterials 2019, 9, 1345 21 of 26
magnetic nanoclusters, the latter were mixed with a trypsin solution, and the Fe@C-NH2/Protein/Str
size was monitored within 24 h. We used trypsin at high concentration (100 µg/mL), similar to that of
the intestinal secretion of a human adult (approx. 100–500 µg/mL) [83], to provide an accelerated study.
An almost two-fold drop in the mean diameter of gelatin-coated nanoclusters was observed after
1 h of incubation (Figure 10) without further changes. Conversely, only a slight decrease in BSA-
and casein-coated nanocluster diameters occurred. After 24 h of agitation at +37 ◦C, the size of the
nanoclusters increased in the control samples (without trypsin) but not in the test samples. In the
previous sections, we noted that all conjugates were stable to heating; however, in this experiment,
highly diluted (10 µg/mL) suspensions were used without the addition of stabilizers including BSA,
glycerol, and glycine. These results demonstrate that stabilizers are essential for the preservation
of conjugates’ properties. Interestingly, after the trypsin treatment, the Z-average diameter of the
gelatin-coated nanoclusters was approximately 60–80 nm, which is equal to that of the parent Fe@C-NH2.
A possible explanation for the different stabilities of coatings to proteolytic digestion is given below.
According to [84], the trypsin degradation rate of albumin nanoparticles covalently linked with
glutaraldehyde is inversely proportional to the cross-linking degree, and only 9% of nanoparticles
degraded within 24 h. Similar results were obtained for the ionically cross-linked casein nanoparticles [85].
In our work, we used a great molar excess of glutaraldehyde capable of involving all available primary
amine groups in cross-linking reactions. Gelatins A and B contain the lowest amount (3.29% and 4.01%)
of lysine [86] in comparison with that of casein (8.10%) and BSA (15.30%) [87,88]; therefore, fewer
cross-links are formed between the primary amines of gelatin molecules [89]. Other factors such as
conformation differences among the adsorbed proteins and their availability to proteolytic cleavage
can also contribute to higher/lower resistance of nanoparticles to trypsinolysis. For example, Cao et al.
demonstrated that adsorption on titanium dioxide nanoparticles can protect casein against gastric and
intestinal digestion [90], and gold nanoparticles coated with proteins were stable for several days in
PBS containing a proteolytic enzyme [91].
4. Conclusions
Protein coatings endow nanoparticles with several favorable properties, enhancing their performance
in various biomedical applications. In the present study, we synthesized nanoclusters of magnetic
iron-carbon nanoparticles coated with four proteins (BSA, casein from bovine milk, and gelatins A and B),
examined their physical-chemical properties from the perspective of applications for in vitro diagnostics
and used nanoclusters conjugated with Streptococcal protein G as labels in an NMR immunoassay of
IgG against the tetanus toxoid. The developed immunoassay allows for the determination of protection
against tetanus in patients vaccinated with the diphtheria-tetanus-pertussis vaccine.
All types of protein coatings provide the nanoclusters with an excellent long-term storage stability.
The gelatin layer prevents nanoclusters from aggregating over a wide range of pH: from 4 to 10, whereas
casein- and BSA-coated nanoclusters are stable at pH 6–10. The protein-coated nanoclusters withstand
salt concentrations up to 2 M without a significant change in size. We demonstrated that protein-coated
magnetic nanoparticles maintain their size in complex media (juice, milk, serum, and plasma) and
at elevated temperatures, facilitating their applications in homogeneous assays of biomarkers and
foodborne pathogens, as well as their analyses based on the amplification of nucleic acids. The type of
protein coating and size of nanocluster do not significantly affect the r2 relaxivity of nanoclusters or
their performance in NMR-assays. Generally, the transverse relaxivity of protein-coated nanoclusters
was between 200 and 350 1/mM−1 × s−1.
We suppose that the developed protein-coated nanoclusters can be applied for not only in vitro
but also in vivo diagnostics (e.g., as a T2 contrast in MRI) due to their good stability in physiological
media and high relaxivity (in comparison with clinically approved nanolabels) [23]. The proteins are
biocompatible and biodegradable; moreover, the protein layer can be loaded with therapeutics or
various labels, providing multimodal imaging.
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